Epigenetics as a paradigm for cancer treatment [electronic resource] : chemically targeting the histone lysine methyltransferase EZH2 / Sharad K. Verma.

By: Verma, Sharad K [spk]Material type: FilmFilmSeries: Henry Stewart talksBiomedical & life sciences collection: Publisher: London : Henry Stewart Talks, 2015Description: 1 online resource (1 streaming video file (21 min.) : color, sound)Subject(s): Cancer -- Genetic aspects | Cancer -- Treatment | Epigenesis | Antineoplastic Agents -- pharmacology | Drug Discovery -- methods | Epigenesis, Genetic -- drug effects | Epigenesis, Genetic | Histone-Lysine N-Methyltransferase -- antagonists & inhibitors | Histones -- metabolism | Methyltransferases -- antagonists & inhibitors | Molecular Targeted Therapy -- methods | Neoplasms -- diagnosis | Neoplasms -- drug therapy | Neoplasms -- geneticsOnline resources: Click here to access online
Contents:
Contents: Cancer as an unmet medical need -- Epigenetics as a paradigm for treating cancer -- Histone lysine methyltransferase EZH2 as a target class example -- Development of EZH2 inhibitors.
Tags from this library: No tags from this library for this title. Log in to add tags.
    Average rating: 0.0 (0 votes)
No physical items for this record

Animated audio-visual presentation with synchronized narration.

Title from title frames.

Contents: Cancer as an unmet medical need -- Epigenetics as a paradigm for treating cancer -- Histone lysine methyltransferase EZH2 as a target class example -- Development of EZH2 inhibitors.

Access restricted to subscribers.

Mode of access: World Wide Web.

Technical University of Mombasa
Tom Mboya Street, Tudor 90420-80100 , Mombasa Kenya
Tel: (254)41-2492222/3 Fax: 2490571